Family Medicine Doctors in Manor, TX Accepting Medicare

9 Family Medicine doctors found. Showing 1 - 9

Dr. Lynda Mueller, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 600 W Carrie Manor St, Manor, TX 78653 Phone: 512-978-9780    Fax: 512-901-9739

Jennifer Mitchell, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 11300 Us Highway 290 E Ste 230, Manor, TX 78653 Phone: 512-582-6075    Fax: 512-406-6275

Dr. Karen V Smith, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 12436 Gregg Manor Rd, Manor, TX 78653 Phone: 512-654-4400    Fax: 512-654-4401

Dominick Andrew Ruiz, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 11300 Hwy 290 East, Bldg 2, Ste 230, Manor, TX 78653 Phone: 512-582-6075    Fax: 512-406-6275

Maria Catalina Cuervo, MD, MPH Family Medicine Medicare: Medicare Enrolled Practice Location: 14008 Shadowglen Blvd Ste 302, Manor, TX 78653 Phone: 512-978-9780    Fax: 512-901-9739

Marilyn Ruiz, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 14001 Shadow Glen Blvd, Suite G, Manor, TX 78653 Phone: 512-272-4451    Fax: 512-590-7319

Eric Spencer, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 12436 Gregg Manor Rd, Manor, TX 78653 Phone: 512-654-4400    Fax: 512-654-4401

Farron Cheryl Hunt, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 11300 Hwy 290 East, Bldg 2, Suite 230, Manor, TX 78653 Phone: 512-582-6075    Fax: 512-406-6275

Dr. Peyton Thompson, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 11416 Runnel Ridge Rd, Manor, TX 78653 Phone: 512-760-0666    Fax: 866-265-1725

News Archive

Phosphate binder drug does not reduce heart disease risk in people with chronic kidney disease

Following a large-scale clinical trial, researchers have found that lanthanum carbonate does not reduce the risk of cardiovascular disease developing in patients with chronic kidney disease.

Stroke Telemedicine: An interview with Séamus Watson

Stroke is the third largest cause of death in England. (1) It is a condition that requires rapid assessment and treatment to reduce deaths, disability and the risk of having another stroke. (2)

CPX-351 treatment leads to higher chances of remission in AML patients, says study

Moffitt Cancer Center researchers say clinical trials for a new experimental drug to treat acute myeloid leukemia (AML) are very promising. Patients treated with CPX-351, a combination of the chemotherapeutic drugs cytarabine and daunorubicin, are showing better responses than patients treated with the standard drug formulation.

Ipsen's Somatuline Depot Injection 120 mg receives FDA approval for treatment of GEP-NETs

Ipsen Biopharmaceuticals, Inc., an affiliate of Ipsen, today announced that Somatuline Depot (lanreotide) Injection 120 mg (referred to as Somatuline) was approved by the U.S. Food and Drug Administration for the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in adult patients with unresectable, well or moderately differentiated, locally advanced or metastatic disease to improve progression-free survival (PFS).

Read more Medical News

› Verified 1 days ago